XML 57 R33.htm IDEA: XBRL DOCUMENT
v3.24.1.u1

EARNINGS PER SHARE (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2024
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Share | The table below presents the computation of basic and diluted earnings per share (in millions, except for per share information):
|  |  | Three Months Ended March 31,
|  |  |  |  | 2024 |  | 2023
Basic: |  |  |  |  |  |  |
Net income attributable to Edwards Lifesciences Corporation |  |  |  |  | $ | 351.9 |  |  | $ | 340.5 |
Weighted-average shares outstanding |  |  |  |  | 601.6 |  |  | 607.5 |
Basic earnings per share |  |  |  |  | $ | 0.58 |  |  | $ | 0.56 |
Diluted: |  |  |  |  |  |  |
Net income attributable to Edwards Lifesciences Corporation |  |  |  |  | $ | 351.9 |  |  | $ | 340.5 |
Weighted-average shares outstanding |  |  |  |  | 601.6 |  |  | 607.5 |
Dilutive effect of stock plans |  |  |  |  | 2.5 |  |  | 3.4 |
Dilutive weighted-average shares outstanding |  |  |  |  | 604.1 |  |  | 610.9 |
Diluted earnings per share |  |  |  |  | $ | 0.58 |  |  | $ | 0.56 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration